SomaLogic, Inc.
SomaLogic, Inc.
Your view on SLGCW
Overview
What the company does, where it operates, and who runs it.
About SomaLogic, Inc.
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Stephen A. Williams BS, MB,
- Headquarters
- 2945 Wilderness Place, Boulder, CO, US
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Stephen A. Williams BS, MB,
- Headquarters
- 2945 Wilderness Place, Boulder, CO, US
SomaLogic, Inc., established in 1999 and based in Boulder, Colorado, is a prominent player in the United States specializing in the identification of protein biomarkers and clinical diagnostic solutions. The company's core technological offering centers on its proprietary slow off-rate modified aptamers, known as SOMAmers – these are uniquely engineered nucleic acid-based reagents designed for precise protein binding. Complementing this, SomaLogic provides SomaScan services, a platform that enables the high-throughput detection and quantification of numerous protein levels within diverse and complex biological samples. This integrated SOMAmers/SomaScan technology empowers researchers to pinpoint crucial protein biomarker signatures across various biological sample types, which are then leveraged for advancements in drug discovery and development efforts. Furthermore, the valuable biomarker insights generated by SomaScan find diagnostic applications in a range of health areas, including cardiovascular and metabolic disorders, nonalcoholic steatohepatitis, and general wellness evaluations. Beyond its core services, SomaLogic also supplies SomaSignal products for research use and as laboratory-developed tests. The company primarily caters to research and clinical clientele, with a significant focus on pharmaceutical and biotechnology companies, as well as academic research institutions. Through its offerings, SomaLogic contributes to accelerating drug development, enhancing the analysis of clinical trials, and deepening our understanding of human biology by investigating intricate protein-protein and protein-gene networks.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for SomaLogic, Inc., and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for SomaLogic, Inc.. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for SomaLogic, Inc.. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for SomaLogic, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for SomaLogic, Inc.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
SomaLogic, Inc. valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold SomaLogic, Inc., and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by SomaLogic, Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming SomaLogic, Inc.. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming SomaLogic, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for SomaLogic, Inc.. Press releases and market coverage, newest first.